Journal of Psychiatry & Neuroscience Journal

Overview
Identity
View All

publication venue for

Investigating the interaction between the human gut microbiome and clozapine therapy in schizophrenia 2022
Atypical antipsychotics, dystonia, and psychotic depression: old solutions for new problems. 47:E194-E195. 2022
Moral wounds run deep: exaggerated midbrain functional network connectivity across the default mode network in posttraumatic stress disorder. 47:E56-E66. 2022
Binge eating disorder hidden behind a wall of anxiety disorders. 46:E208-E209. 2021
DCC gene network in the prefrontal cortex is associated with total brain volume in childhood. 46:E154-E163. 2021
Cannabis involvement and neuropsychological performance: findings from the Human Connectome Project. 44:414-422. 2019
The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols. 44:223-236. 2019
The microbiome and mental health: Hope or hype?. 44:219-222. 2019
Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a meta-analysis of randomized controlled trials over 2 decades. 44:151-163. 2019
Age-related deficits in intracortical myelination in young adults with bipolar disorder type I. 44:79-88. 2019
Resting-state functional connectivity in individuals with bipolar disorder during clinical remission: a systematic review. 43:298-316. 2018
Resting-state functional connectivity in individuals with bipolar disorder during clinical remission: a systematic review.. 43:298-316. 2018
Mindfulness-based treatments for posttraumatic stress disorder: a review of the treatment literature and neurobiological evidence. 43:7-25. 2018
Mindfulness-based treatments for posttraumatic stress disorder: a review of the treatment literature and neurobiological evidence.. 43:7-25. 2018
The gut microbiota and psychiatric illness. 42:75-77. 2017
Refractory social anxiety disorder. 42:E1-E2. 2017
Concepts and misconceptions regarding clinical staging models. 41:E84-E85. 2016
Concepts and misconceptions regarding clinical staging models : Author response.. 41:E83-E84. 2016
Staging model raises fundamental questions about the nature of bipolar disorder. 41:291-293. 2016
Treating comorbid premenstrual dysphoric disorder in women with bipolar disorder. 41:E22-E23. 2016
Topiramate augmentation in a patient with obsessive–compulsive disorder. 40:E31-E32. 2015
Systematic review of the neural basis of social cognition in patients with mood disorders. 37:154-169. 2012
Stress response in postpartum women with and without obsessive–compulsive symptoms: an fMRI study. 37:78-86. 2012
Abnormal hippocampal activation in patients with extensive history of major depression: an fMRI study. 37:28-36. 2012
Managing anxiety and depressive symptoms in adults with autism-spectrum disorders. 36:E35-E36. 2011
Default mode alterations in posttraumatic stress disorder related to early-life trauma: a developmental perspective. 36:56-59. 2011
Is there a role for estrogen in treating depression during menopause?. 35:E6-E7. 2010
Autism spectrum disorders, schizophrenia and diagnostic confusion. 35:360-360. 2010
Psychopharmacology for the Clinician. 35:360-360. 2010
3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder.. 34:263-271. 2009
Bariatric surgery in patients with bipolar disorder: an emerging issue.. 34:E3-E4. 2009
Effects of gut microbiota on the brain: implications for psychiatry.. 34:230-231. 2009
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder.. 34:175-180. 2009
A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder.. 34:41-54. 2009
Effects of mood stabilizers on DNA damage in an animal model of mania.. 33:516-524. 2008
Implementing antiobesity treatment in a patient with a mood disorder.. 33:E1-E2. 2008
Psychopharmacology for the Clinician. 33:E1-E2. 2008
Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms.. 33:395-404. 2008
A new, female-specific irritability rating scale.. 33:344-354. 2008
Advances in neurobiology, assessment and treatment of female-specific mood disorders. 33:289-290. 2008
Advances in neurobiology, assessment and treatment of female-specific mood disorders: papers from a symposium presented at the joint congress of the Collegium Internationale Neuro-Psychopharmacologicum and the Canadian College of Neuropsychopharmacology, Chicago, July 11, 2006.. 33:289-290. 2008
Premenstrual dysphoric disorder: burden of illness and treatment update.. 33:291-301. 2008
Psychopharmacology for the clinician psychopharmacologie pratique. 33:384-384. 2008
Treating depression during pregnancy.. 33:384. 2008
Subacute alteration in level of consciousness in a woman with psychotic depression.. 33:E1-E2. 2008
Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia.. 32:412-416. 2007
The long-term impact of treatment with electroconvulsive therapy on discrete memory systems in patients with bipolar disorder.. 32:241-249. 2007
Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.. 31:326-332. 2006
Repetitive transcranial magnetic stimulation for the treatment of depression.. 30:434. 2005
Sleep and perinatal mood disorders: a critical review.. 30:247-256. 2005
Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis.. 30:83-90. 2005
Tardive dystonia and its treatment. 28:240-240. 2003
Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia.. 28:39-47. 2003
What's in a name? The evolution of the nomenclature of antipsychotic drugs.. 27:168-175. 2002
Low-dose dexamethasone challenge in women with atypical major depression: pilot study.. 27:47-51. 2002
Antisense technology in the central nervous system.. 26:423-424. 2001
Treatment plans and interventions for depression and anxiety disorders.. 26:422-423. 2001
Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.. 25:459-468. 2000
Use of slow-release melatonin in treatment-resistant depression.. 25:48-52. 2000
Risk management with suicidal patients.. 24:354-355. 1999
Heterogeneity and the genetics of autism.. 24:159-165. 1999
Transcranial magnetic stimulation: using a law of physics to treat psychopathology.. 24:97-101. 1999
Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.. 23:172-178. 1998
A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes.. 21:29-35. 1996
Repeat neurobehavioral study of borderline personality disorder.. 21:13-20. 1996
Melatonin responses to clonidine and yohimbine challenges.. 20:297-304. 1995
Light, melatonin and the sleep-wake cycle.. 19:345-353. 1994
NEUROBIOLOGY IMAGING. 19:39-42. 1994
Neurobiology/imaging panel report: A national strategy for research on schizophrenia. 19:39-42. 1994
A dose-finding study with remoxipride in the acute treatment of schizophrenic patients.. 17:134-145. 1992
The profile of a major affective disorder offender.. 15:11-14. 1990
Psychoneuroendocrinology of depression.. 14:344-348. 1989
The neurochemistry of mood.. 14:342-343. 1989
The heterogeneity/homogeneity of pedophilia.. 13:217-226. 1988
Variations in dexamethasone suppression test results: RIA values exceed CPBA.. 13:122-123. 1988
Sexually aggressive men.. 12:169-175. 1987
A comparative study of adolescents and adults who wilfully set fires.. 11:228-234. 1986
Interface between the Criminal Justice System and the Mental Health System in Canada.. 10:24-33. 1985
The forensic psychiatric aspects of schizophrenia.. 8:96-103. 1983
PSYCHOPATH - COMPREHENSIVE STUDY OF ANTISOCIAL DISORDERS AND BEHAVIORS - REID,WH. 4:268-269. 1979

has subject area